TO

TORII PHARMACEUTICAL CO., LTD.

A pharmaceutical specialist in drugs for renal, skin, and allergic diseases.

4551 | T

Overview

Corporate Details

ISIN(s):
JP3635800000
LEI:
Country:
Japan
Address:
中央区日本橋本町三丁目4番1号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Torii Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the development, manufacturing, and marketing of ethical drugs. The company focuses its business activities on key therapeutic areas, including renal diseases and hemodialysis, skin diseases, and allergies. Its product portfolio addresses conditions such as atopic dermatitis and pruritus associated with chronic kidney disease. Following a tender offer completed in 2025, the company operates as a subsidiary of Shionogi & Co., Ltd.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-07 06:04
Registration Form
確認書
Japanese 9.3 KB
2025-08-07 06:01
Interim Report
半期報告書-第134期(2025/01/01-2025/12/31)
Japanese 215.6 KB
2025-07-10 08:30
Share Issue/Capital Change
臨時報告書
Japanese 215.5 KB
2025-06-19 02:04
Major Shareholding Notification
臨時報告書
Japanese 23.2 KB
2025-06-04 09:05
M&A Activity
訂正意見表明報告書
Japanese 171.8 KB
2025-05-08 08:56
Regulatory News Service
意見表明報告書
Japanese 373.9 KB
2025-03-31 08:30
Post-Annual General Meeting Information
臨時報告書
Japanese 24.8 KB
2025-03-27 07:23
Governance Information
内部統制報告書-第133期(2024/01/01-2024/12/31)
Japanese 24.0 KB
2025-03-27 07:22
Registration Form
確認書
Japanese 9.3 KB
2025-03-27 07:18
Annual Report
有価証券報告書-第133期(2024/01/01-2024/12/31)
Japanese 1.0 MB
2024-08-01 03:06
Interim Report
確認書
Japanese 9.2 KB
2024-08-01 03:05
Interim Report
半期報告書-第133期(2024/01/01-2024/12/31)
Japanese 187.0 KB
2024-04-26 08:07
Report Publication Announcement
確認書
Japanese 9.2 KB
2024-04-26 08:06
Quarterly Report
四半期報告書-第133期第1四半期(2024/01/01-2024/03/31)
Japanese 143.5 KB
2024-03-29 07:17
Post-Annual General Meeting Information
臨時報告書
Japanese 39.3 KB

Automate Your Workflow. Get a real-time feed of all TORII PHARMACEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TORII PHARMACEUTICAL CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TORII PHARMACEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ECO ANIMAL HEALTH GROUP PLC Logo
Develops pharmaceuticals for respiratory & enteric diseases in global swine and poultry markets.
United Kingdom EAH
Ectin Research AB Logo
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden ECTIN B
Edesa Biotech, Inc. Logo
Develops treatments for inflammatory and immune diseases like Acute Respiratory Distress Syndrome.
United States of America EDSA
Edgewise Therapeutics, Inc. Logo
Developing novel therapeutics for rare and serious muscle disorders.
United States of America EWTX
Editas Medicine, Inc. Logo
Developing CRISPR-based genomic medicines to treat serious and rare genetic diseases.
United States of America EDIT
Eevia Health Plc Logo
Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.
Finland EEVIA
Egetis Therapeutics Logo
Develops and commercializes drugs for serious rare diseases with unmet medical needs.
Sweden EGTX
EIKEN CHEMICAL CO.,LTD. Logo
Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.
Japan 4549
Eisai Co., Ltd. Logo
A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.
Japan 4523
Elanco Animal Health Inc Logo
Develops medicines, vaccines, and services to treat and prevent disease in pets and farm animals.
United States of America ELAN

Talk to a Data Expert

Have a question? We'll get back to you promptly.